参考文献/References:
[1]Wilkinson L,Gathani T.Understanding breast cancer as a global health concern[J].Br J Radiol,2022,95(1130):20211033.[2]高可欣,李文媛,赵微,等.TNF-ɑ调控LRG1促进乳腺癌MCF-7细胞增殖、侵袭和迁移[J].现代肿瘤医学,2024,32(8):1424-1429.[3]顾家徐,周欣悦,柯国琳,等.核转运蛋白α2基因沉默对黑色素瘤细胞增殖和侵袭能力的影响[J].实用临床医药杂志,2023,27(4):97-103.[4]张玲娜,甘梅富,周梦雅,等.胞核中核转运受体蛋白Karyo-pherin alpha 2水平与胃癌预后的关系研究[J].浙江医学,2021,43(10):1042-1045,1141.[5]于利,张明,王迪.miR-4465靶向KPNA2调控宫颈癌细胞增殖、迁移及侵袭的机制研究[J].中国实验诊断学,2021,25(5):744-749.[6]马艳丽,杨靖,吕梦丽.KAI1,Snail, Slug, E-cadherin在鼻咽癌组织中的表达及其与患者预后的关系[J].实用癌症杂志,2023,38(4):562-564,568.[7]梁晶,陈立军,于津生,等.肺癌外周血MMP-7 mRNA与肿瘤免疫微环境特征的相关性研究[J].检验医学与临床,2023,20(18):2650-2653,2658.[8]Cui X,Wang H,Wu X,et al.Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling[J].J Ovarian Res,2021,14(1):71.[9]Zeng Q,Feng K,Yu Y,et al.Hsa_Circ_0000021 Sponges miR-3940-3p/KPNA2 Expression to Promote Cervical Cancer Progression[J].Curr Mol Pharmacol,2024,17(1):e170223213775.[10]Chen T,Liu R,Niu Y,et al.HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway[J].Cell Death Dis,2021,12(12):1152.[11]Zeng F,Luo L,Li D,et al.KPNA2 interaction with CBX8 contributes to the development and progression of bladder cancer by mediating the PRDM1/c-FOS pathway[J].J Transl Med,2021,19(1):112.[12]魏微微,高圣钰,孟凡石.miR-100-5p调控甲状腺乳头状癌细胞的增殖、迁移、侵袭及EMT进程[J].现代肿瘤医学,2023,31(22):4123-4129.[13]王燕,张宝,王交莉.TIPE2过表达调控Wnt/β-catenin抑制胃癌细胞增殖、迁移和EMT[J].中国免疫学杂志,2023,39(8):1700-1705.[14]张雪,赵丽丽,闫文娴,等.HER-2对胃癌细胞生物学行为及EMT、Wnt通路的影响[J].临床肿瘤学杂志,2023,28(7):585-591.[15]刘玉强,刘丛,李乐其.结直肠癌组织SDF-1、Ephrin B2、ZNF545表达与EMT标志物、临床病理特征和预后的关系[J].检验医学与临床,2023,20(11):1592-1596,1602.[16]孙绪高,杨文超,刘彦杰,等.茶黄素调节Snail/Slug信号通路对口腔鳞癌细胞生物学行为的影响[J].天津医药,2023,51(11):1164-1170.[17]吕本洁,周孝峰,王伟隆,等.食管鳞癌组织Snail与PDL-1和CD8+T表达及预后分析[J].中华肿瘤防治杂志,2023,30(2):78-83,103.[18]胡鹏,朱小鹏.基质金属蛋白酶-7、9基因多态性与卵巢癌遗传易感性的相关性研究[J].宁夏医科大学学报,2022,44(8):768-773.[19]王一凡,刘爽,汪思齐,等.急性马兜铃酸中毒小鼠肾损伤及Wnt7b/β-catenin/MMP-7的表达变化[J].中国医科大学学报,2023,52(6):505-511.[20]徐阳,范瑞.肺腺癌组织中COX-2、MMP-7的表达及临床意义[J].实验与检验医学,2022,40(1):73-76.
相似文献/References:
[1]董 云.SPECT/CT 双时相99mTc- MIBI断层显像
在乳腺癌诊断中的应用[J].医学信息,2018,31(05):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
DONG Yun.Application of SPECT/CT Dual-phase 99mTc-MIBI Tomography in the Diagnosis of Breast Cancer[J].Journal of Medical Information,2018,31(01):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
[2]李建辉,祝旭龙.乳腺癌的治疗管理——把好生活质量关[J].医学信息,2018,31(13):1.[doi:10.3969/j.issn.1006-1959.2018.13.001]
[3]杨玉峰,李 强,曲国红,等.乳腺癌术前巴德枪穿刺检测ER、PR的临床研究[J].医学信息,2018,31(13):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
YANG Yu-feng,LI Qiang,QU Guo-hong,et al.Clinical Study on Preoperative ER and PR Detection of Bard Gun Puncture in Breast Cancer[J].Journal of Medical Information,2018,31(01):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
[4]刘 曼,厉玛倩倩,徐润润,等.延续性护理对乳腺癌术后化疗患者生活质量与
健康知识水平的影响[J].医学信息,2018,31(16):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
LIU Man,LIMA Qian-qian,XU Run-run,et al.Effect of Continuous Nursing on Quality of Life and Health Knowledge of Postoperative Chemotherapy Patients with Breast Cancer[J].Journal of Medical Information,2018,31(01):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
[5]张艳萍,曹 玉,孙国平.服用阿司匹林对乳腺癌患者生存获益的Meta分析[J].医学信息,2018,31(20):72.[doi:10.3969/j.issn.1006-1959.2018.20.021]
ZHANG Yan-ping,CAO Yu,SUN Guo-ping.Meta Analysis of the Survival Benefit of Patients with Breast Cancer Treated with Aspirin[J].Journal of Medical Information,2018,31(01):72.[doi:10.3969/j.issn.1006-1959.2018.20.021]
[6]钟 磊,谢海燕,林 霖.电化学发光免疫分析技术检测肿瘤标志物在乳腺癌诊断中的应用[J].医学信息,2018,31(20):155.[doi:10.3969/j.issn.1006-1959.2018.20.048]
ZHONG Lei,XIE Hai-yan,LIN Lin.Application of Electrochemiluminescence Immunoassay for Detection of Tumor Markers in Diagnosis of Breast Cancer[J].Journal of Medical Information,2018,31(01):155.[doi:10.3969/j.issn.1006-1959.2018.20.048]
[7]胡平华,黄 勤,李志华.含卡培他滨方案一线或后线治疗晚期乳腺癌的效果对比[J].医学信息,2018,31(22):142.[doi:10.3969/j.issn.1006-1959.2018.22.041]
HU Ping-hua,HUANG Qin,LI Zhi-hua.Comparison of the Efficacy of Capecitabine Regimen in the Treatment of Advanced Breast Cancer with First-line or Posterior Line Therapy[J].Journal of Medical Information,2018,31(01):142.[doi:10.3969/j.issn.1006-1959.2018.22.041]
[8]阙海涛,曹 斌,秦志刚.EGFL7在乳腺癌中的研究进展[J].医学信息,2018,31(23):32.[doi:10.3969/j.issn.1006-1959.2018.23.010]
QUE Hai-tao,CAO Bin,QIN Zhi-gang.Research Progress of EGFL7 in Breast Cancer[J].Journal of Medical Information,2018,31(01):32.[doi:10.3969/j.issn.1006-1959.2018.23.010]
[9]张文婧,宋 冰.HER-2阳性乳腺癌分子靶向治疗进展[J].医学信息,2018,31(24):42.[doi:10.3969/j.issn.1006-1959.2018.24.012]
ZHANG Wen-jing,SONG Bing.Progress in Molecular Targeted Therapy for HER-2 Positive Breast Cancer[J].Journal of Medical Information,2018,31(01):42.[doi:10.3969/j.issn.1006-1959.2018.24.012]
[10]张 乐,徐胜昔,郭翔取,等.Tyrer-Cuzick模型联合SNPs位点在江西地区乳腺癌诊断中应用研究[J].医学信息,2018,31(24):131.[doi:10.3969/j.issn.1006-1959.2018.24.038]
ZHANG Le,XU Sheng-xi,GUO Xiang-qu,et al.Application of Tyrer-Cuzick Model Combined with SNPs Locus in the Diagnosis of Breast Cancer in Jiangxi Area[J].Journal of Medical Information,2018,31(01):131.[doi:10.3969/j.issn.1006-1959.2018.24.038]
[11]魏丽丽,郝瑞卿,王华瑛.KPNA2在乳腺癌组织中的表达及临床病理意义[J].医学信息,2022,35(18):53.[doi:10.3969/j.issn.1006-1959.2022.18.012]
WEI Li-li,HAO Rui-qing,WANG Hua-ying.The Expressions of KPNA2 in the Breast Cancer and its Clinicopathological Significance[J].Journal of Medical Information,2022,35(01):53.[doi:10.3969/j.issn.1006-1959.2022.18.012]